Aerocrine: The American Thoracic Society & AAAAI Issue a Joint Position Statement in Support of the American Thoracic Society Guidelines on FeNO  
4/2/2012 10:56:39 AM

SOLNA, Sweden--(BUSINESS WIRE)--Regulatory News: Aerocrine AB (OMX Nordic Exchange: AERO) announces that a nine-member council representing both prestigious asthma societies, the American Academy and the American College of Allergy, Asthma and Immunology (ACAAI and AAAAI), have published a position statement in support of the clinical practice guideline on Aerocrine’s FeNO test as published by the ATS.